Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myelodysplastic Syndromes, Adult”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00619645
What this trial is testing

Donor Peripheral Stem Cell Transplant, Fludarabine, and Busulfan in Treating Patients With Hematologic Cancers

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of California, Davis 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT05796570
What this trial is testing

A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromesMyeloid Malignancies+4 more
Franziska Wachter 29
Early research (Phase 1)Study completedNCT00049686
What this trial is testing

VNP40101M in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Vion Pharmaceuticals
Not applicableStudy completedNCT00956475
What this trial is testing

Quality of Life in Younger Leukemia and Lymphoma Survivors

Who this might be right for
Anxiety DisorderCancer SurvivorFatigue+7 more
Case Comprehensive Cancer Center 48
Not applicableStudy completedNCT01951430
What this trial is testing

Observational Evaluation of Infective Risk in Myelodysplastic Syndrome Patients

Who this might be right for
Myelodysplastic Syndrome
Gruppo Italiano Malattie EMatologiche dell'Adulto 229
Testing effectiveness (Phase 2)Study completedNCT01772420
What this trial is testing

Phase II Study of Lenalidomide and Eltrombopag in Patients With Symptomatic Anemia

Who this might be right for
Adult Myelodysplastic SyndromeAnemiaChronic Myelomonocytic Leukemia
Albert Einstein College of Medicine 52
Large-scale testing (Phase 3)Looking for participantsNCT06829472
What this trial is testing

Conditioning Regimen of Melphalan-busulfan and Fludarabine: a Randomized Study of Different Dose of Melphalan

Who this might be right for
ToxicitiesSurvivorship
Shanghai Jiao Tong University School of Medicine 120
Testing effectiveness (Phase 2)Study completedNCT01729845
What this trial is testing

Decitabine Followed by Mitoxantrone Hydrochloride, Etoposide, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

Who this might be right for
Previously Treated Myelodysplastic SyndromeRecurrent Adult Acute Myeloid Leukemia
Fred Hutchinson Cancer Center 52
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07738510
What this trial is testing

Evaluate Ofirnoflast in Adults With Very Low- to Intermediate-risk Myelodysplastic Syndromes Requiring Transfusions

Who this might be right for
Myelodysplastic SyndromesAnemia
Halia Therapeutics, Inc. 50
Early research (Phase 1)Looking for participantsNCT03017820
What this trial is testing

A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma

Who this might be right for
B-Cell Non-Hodgkin LymphomaHistiocytic and Dendritic Cell NeoplasmMyelodysplastic Syndrome+16 more
Mayo Clinic 99
Early research (Phase 1)Study completedNCT00019656
What this trial is testing

Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+2 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00015951
What this trial is testing

Bevacizumab, Cytarabine, and Mitoxantrone on Treating Patients With Hematologic Cancers

Who this might be right for
LeukemiaMyelodysplastic Syndromes
University of Maryland, Baltimore
Not applicableWithdrawnNCT04331483
What this trial is testing

Assess a Physical Activity Program in Children, Adolescents and Young Adults Requiring Hematopoietic Stem Cell Allografts

Who this might be right for
Haematological MalignancyAcute LeukemiaMyelodysplastic Syndromes+3 more
Centre Leon Berard
Early research (Phase 1)Study completedNCT06294301
What this trial is testing

Single and Multiple Doses of LP-005 in Healthy Adult Participants

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Longbio Pharma 68
Not applicableStudy completedNCT00920842
What this trial is testing

Study of Metabolic Syndrome in Adolescent and Young Adult Survivors of Childhood Leukemia Who Have Undergone Stem Cell Transplant

Who this might be right for
Cardiovascular ComplicationsLeukemiaLong-term Effects Secondary to Cancer Therapy in Children+1 more
Fred Hutchinson Cancer Center 244
Early research (Phase 1)Study completedNCT06852092
What this trial is testing

Study on Mass Balance of [14C]HSK39297 in Healthy Chinese Adult Male Subjects

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Haisco Pharmaceutical Group Co., Ltd. 7
Testing effectiveness (Phase 2)Study completedNCT00270881
What this trial is testing

Safety and Efficacy of Unrelated Cord Blood Transplantation for Adult Patients With Hematologic Malignancies

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia+1 more
Keio University 33
Testing effectiveness (Phase 2)Study completedNCT00084916
What this trial is testing

CCI-779 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Chronic Myelogenous Leukemia in Blastic Phase

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+12 more
National Cancer Institute (NCI) 74
Testing effectiveness (Phase 2)UnknownNCT05061147
What this trial is testing

Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of Max-40279-01 in Combination With Azacitidine (AZA) in Patients With Myelodysplastic Syndrome (MDS) or Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)

Who this might be right for
LeukemiaAcute Myeloid LeukemiaRelapsed/Refractory Acute Myeloid Leukemia+1 more
Maxinovel Pty., Ltd. 100
Early research (Phase 1)Study completedNCT00006040
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy and Etoposide Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Myelodysplastic Syndrome or Refractory Leukemia

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Memorial Sloan Kettering Cancer Center
Next Page